Arthropathy affecting multiple joint sites as a direct manifestation of another specified underlying disease coded elsewhere in ICD-10-CM — not a standalone primary diagnosis.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M14.89.
Source · Editorial brief grounded in 5 cited references ↓
- Identify and document the underlying systemic disease by name and code it first — M14.89 is a manifestation code and cannot stand alone on a claim without the primary diagnosis preceding it.
- Specify which joints are involved by name and side (e.g., bilateral knees, right wrist, left ankle) to justify 'multiple sites' and to support the clinical picture if audited.
- Record the clinical basis linking the underlying disease to the joint findings — lab values, imaging, or specialist confirmation that the arthropathy is attributable to the systemic condition.
- Confirm the underlying disease is not in the M14 Type 1 Excludes list before assigning M14.89; if it is, redirect to the designated code (e.g., diabetic arthropathy under E08–E13 with .61-).
- If only one joint region is affected, downcode to the site-specific M14.8x code (e.g., M14.851 for right hip) rather than using M14.89 for multiple sites.
Related CPT procedures
Procedure codes commonly billed with M14.89. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M14.89 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M14.89 as the first-listed or principal diagnosis — it is a manifestation code; the underlying disease must be sequenced first per the Code First instruction at M14.8.
- Using M14.89 when the underlying condition falls within the Type 1 Excludes block at M14 (e.g., coding M14.89 for a diabetic patient with polyarticular neuropathic arthropathy instead of the correct E08–E13 combination code).
- Selecting M14.89 for single-site arthropathy — if only one joint region is involved, the more specific site-coded sibling under M14.81–M14.88 is required.
- Pairing M14.89 with amniotic or placental-derived product injection CPT codes without anticipating the CMS non-coverage flag (CMS LCD Article A59764 explicitly lists M14.89 as not supporting medical necessity for those procedures).
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M14.89 is a manifestation code for joint disease involving multiple sites that arises from an underlying systemic or specified disease not captured within the Type 1 Excludes list at the M14 category level. The underlying condition must be coded first (Code First instruction at M14.8). Common underlying conditions routed here include acromegaly, hemochromatosis, Whipple's disease, or other specified metabolic and systemic disorders that produce polyarticular joint involvement but are not explicitly addressed by more specific codes in the ICD-10-CM tabular.
Before assigning M14.89, confirm the underlying disease is not already excluded at the M14 level. The M14 category carries a Type 1 Excludes block that redirects arthropathy in diabetes mellitus (E08–E13 with .61-), hematological disorders (M36.2–M36.3), hypersensitivity reactions (M36.4), neoplastic disease (M36.1), neurosyphilis (A52.16), sarcoidosis (D86.86), enteropathic arthropathies (M07.-), juvenile psoriatic arthropathy (L40.54), and lipoid dermatoarthritis (E78.81) to their own dedicated codes. Assign M14.89 only when the underlying disease is "other specified" and genuinely falls outside that exclusion list.
Use M14.89 specifically when joint involvement is documented at multiple sites and no single-site code under M14.8 (M14.81–M14.88) covers the full picture. If joint involvement is limited to one anatomical region, select the laterality-specific code for that site instead. CMS has listed M14.89 among codes that do not support medical necessity for amniotic and placental-derived product injections (CMS Article A59764), so be prepared for payer scrutiny on procedure pairing.
Sibling codes
Other billable codes under M14.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Can M14.89 be the first-listed diagnosis on a claim?
02Which underlying diseases are excluded from M14.89 by a Type 1 Excludes note?
03When should I use M14.89 versus a single-site M14.8x code?
04Does M14.89 require a 7th character extension?
05Why was my claim for an injection procedure denied when M14.89 was listed?
06Is M14.89 appropriate for Charcot's joint affecting multiple sites?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M14-/M14.89
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M14.89
- 04cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=59764&ver=7
- 05icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M14-
Mira AI Scribe
Mira captures the underlying systemic disease, the specific joints involved by name and laterality, imaging findings (e.g., periarticular erosions, joint space narrowing), and any lab or specialist findings linking the arthropathy to that disease. This prevents the claim from being submitted with M14.89 as the first-listed code — a sequencing error that triggers edits — and ensures the 'multiple sites' designation is clinically supported rather than a default fallback.
See how Mira captures M14.89 documentation